Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study

Max Augustin, Philipp Schommers, Melanie Stecher, +23

The Lancet Regional Health - Europe

Virus EpidemiologyNon-hospitalised PatientsCovid-19 PandemicPost-covid SyndromeCovid-19 Epidemiology +3

<scp>SARS</scp> ‐CoV‐2 targets neurons of 3D human brain organoids

Anand Ramani, Lisa Müller, Philipp Niklas Ostermann, +20

The EMBO Journal

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Pilar Mendoza, Henning Gruell, Lilian Nogueira, +33

Nature

Human RetrovirusImmunologyAntiviral TherapyAntiviral ResponseVirology +4

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice

Florian Klein, Ariel Halper-Stromberg, Joshua A. Horwitz, +20

Nature

Human RetrovirusImmunologyAntiviral TherapyAntiviral ResponseAntibody Engineering +5

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Marina Caskey, Till Schoofs, Henning Gruell, +34

Nature Medicine

Hiv-1-infected IndividualsHuman RetrovirusImmunologyAntiviral ResponseVirology +5

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

Henning Gruell, Kanika Vanshylla, Pinkus Tober‐Lau, +6

Nature Medicine

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

Christoph Kreer, Matthias Zehner, Timm Weber, +25

Cell

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau, +68

The Lancet Respiratory Medicine

VaccinationImmunodeficienciesImmunologyImmunologic MechanismImmunotherapeutics +4

Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals

Yotam Bar‐On, Henning Gruell, Till Schoofs, +30

Nature Medicine

Viremic IndividualsAntiviral ActivityHuman RetrovirusImmunologyAntiviral Response +8

Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans

Kanika Vanshylla, Veronica Di Cristanziano, Franziska Kleipass, +23

Cell Host & Microbe

VaccinationSars-cov-2 InfectionVaccine TargetHumoral ResponseImmunology +6